Oberhaching, Germany

Renate Lafuntal

This inventor holds 1 USPTO granted patent. Top assignee: Hexal Ag. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Renate Lafuntal. Retrieved from https://idiyas.com/inventor/renate-lafuntal

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Renate Lafuntal: Innovator in Antibody Preparation

Introduction

Renate Lafuntal is a prominent inventor based in Oberhaching, Germany. She has made significant contributions to the field of biotechnology, particularly in the development of antibody preparations. Her innovative work has led to the creation of novel methods that enhance the quality and efficacy of antibody treatments.

Latest Patents

Renate holds 1 patent related to her groundbreaking work. The patent focuses on antibody preparation, specifically addressing the removal of glycosylated antibody variants from an antibody preparation. This invention not only improves the purity of antibody products but also contributes to the advancement of pharmaceutical compositions that utilize these antibodies.

Career Highlights

Renate is currently associated with Hexal AG, a company known for its commitment to pharmaceutical innovation. Her role at Hexal AG allows her to collaborate with other experts in the field and further her research in biotechnology.

Collaborations

Throughout her career, Renate has worked alongside talented colleagues, including Claudia Torella and Benjamin Hackner. These collaborations have fostered a dynamic environment for innovation and have contributed to the success of their projects.

Conclusion

Renate Lafuntal's contributions to antibody preparation exemplify the impact of innovative thinking in biotechnology. Her work continues to influence the development of effective pharmaceutical solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…